Assessment of industry data on pulmonary and immunosuppressive effects of IQOS

INTRODUCTION: Heated tobacco products are being touted as novel reduced-harm tobacco products by tobacco companies. In the USA, Philip Morris International submitted a modified risk tobacco product (MRTP) application to the US Food and Drug Administration in 2016 in which it purports that its heated...

Descripción completa

Detalles Bibliográficos
Autores principales: Moazed, Farzad, Chun, Lauren, Matthay, Michael A, Calfee, Carolyn S, Gotts, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252496/
https://www.ncbi.nlm.nih.gov/pubmed/30158203
http://dx.doi.org/10.1136/tobaccocontrol-2018-054296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252496/
https://www.ncbi.nlm.nih.gov/pubmed/30158203
http://dx.doi.org/10.1136/tobaccocontrol-2018-054296

Ejemplares similares